Figure 4.
Survival outcomes based upon TP53 mutation and high-risk feature status. PFS for patients with (A) an IPI score ≥ 3, (B) HGBL classification, (C) non–germinal center cell of origin, (D) MYC rearrangement, (E) MYC-BCL2 double-hit lymphoma, and (F) EZB genetic classification based upon TP53 LOF mutation status.

Survival outcomes based upon TP53 mutation and high-risk feature status. PFS for patients with (A) an IPI score ≥ 3, (B) HGBL classification, (C) non–germinal center cell of origin, (D) MYC rearrangement, (E) MYC-BCL2 double-hit lymphoma, and (F) EZB genetic classification based upon TP53 LOF mutation status.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal